Since the 1980s, remarkable advances have been made in bone marrow transplantation (BMT), which is now becoming a powerful tool in the treatment of such diseases as leukaemia, aplastic anaemia and congenital immunodeficiency. This text contains information on how to prevent graft rejection, how T cell functions can be completely restored, and how concomitant BMT can prevent the rejection of organ allografts without the use of immunodepressive agents.

Since the 1980s, remarkable advances have been made in bone marrow transplantation (BMT), which is now becoming a powerful tool in the treatment of such diseases as leukaemia, aplastic anaemia and congenital immunodeficiency. This text contains information on how to prevent graft rejection, how T cell functions can be completely restored, and how concomitant BMT can prevent the rejection of organ allografts without the use of immunodepressive agents.

Since the 1980s, remarkable advances have been made in bone marrow transplantation (BMT), which is now becoming a powerful tool in the treatment of such diseases as leukaemia, aplastic anaemia and congenital immunodeficiency. This text contains information on how to prevent graft rejection, how T cell functions can be completely restored, and how concomitant BMT can prevent the rejection of organ allografts without the use of immunodepressive agents.